Skip to content
PICO Portalanswers from OpenAlex

Efficacy and Safety of Empagliflozin in Renal Transplant Recipients With Posttransplant Diabetes Mellitus

PaperCitations, authors & open-access status

Efficacy and Safety of Empagliflozin in Renal Transplant Recipients With Posttransplant Diabetes Mellitus is a paper indexed in PICO Portal from OpenAlex.

How many citations does Efficacy and Safety of Empagliflozin in Renal Transplant Recipients With Posttransplant Diabetes Mellitus have?

PICO Portalcitation count

Efficacy and Safety of Empagliflozin in Renal Transplant Recipients With Posttransplant Diabetes Mellitus has 216 citations in the OpenAlex counts PICO Portal stores.

When was Efficacy and Safety of Empagliflozin in Renal Transplant Recipients With Posttransplant Diabetes Mellitus published?

PICO Portalyear

Efficacy and Safety of Empagliflozin in Renal Transplant Recipients With Posttransplant Diabetes Mellitus has 2019 year in the PICO Portal index.

What is the open-access status of Efficacy and Safety of Empagliflozin in Renal Transplant Recipients With Posttransplant Diabetes Mellitus?

PICO Portaloa status

Efficacy and Safety of Empagliflozin in Renal Transplant Recipients With Posttransplant Diabetes Mellitus has green oa status in the PICO Portal index.

What is the DOI of Efficacy and Safety of Empagliflozin in Renal Transplant Recipients With Posttransplant Diabetes Mellitus?

PICO Portaldoi

The DOI for Efficacy and Safety of Empagliflozin in Renal Transplant Recipients With Posttransplant Diabetes Mellitus is on the source record.

What is the PMID of Efficacy and Safety of Empagliflozin in Renal Transplant Recipients With Posttransplant Diabetes Mellitus?

PICO Portalpmid

The PMID for Efficacy and Safety of Empagliflozin in Renal Transplant Recipients With Posttransplant Diabetes Mellitus is on the source record.

What is the OpenAlex record for Efficacy and Safety of Empagliflozin in Renal Transplant Recipients With Posttransplant Diabetes Mellitus?

PICO Portalopenalex

The OpenAlex for Efficacy and Safety of Empagliflozin in Renal Transplant Recipients With Posttransplant Diabetes Mellitus is on the source record.

Related on PICO Portal

470M+ articles · 14-day free trial